4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome.
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
D000200:Action Potentials; D000284:Administration, Oral; D018288:Carcinoma, Small Cell / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D009132:Muscles / Q000503:physiopathology; D009135:Muscular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D013577:Syndrome
D011725:Pyridines